New treatment strategies in the management of breast cancer

Perez, Edith A.

doi:10.1016/s1359-6349(11)70006-4

Cited by 2 publications

(1 citation statement)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Enhanced cell replication resulting from estrogen exposure results in the propagation of genetic errors, and the mutagenesis increases the risk of genetic alteration. Although estrogens enhance the growth of certain types of breast cancer cells in cell culture, the detailed mechanisms by which the steroids promote growth in vivo are still not completely clear. − …”

Section: Estrogen Receptors As Targets Of Steroid–drug Conjugatesmentioning

confidence: 99%

Targeting the Estrogen Receptor using Steroid–Therapeutic Drug Conjugates (Hybrids)

Dao

Hanson

2012

Bioconjugate Chem.

View full text Add to dashboard Cite

The estrogen receptor (ER) is a potentially useful biological target for diagnosis and therapy in hormonally responsive human breast cancer. This protein is often overexpressed both on the membrane and on the nuclear compartment of breast cancer cells and therefore provides a mechanism for targeted drug delivery. Over the past 30 years, many research groups have attempted to exploit the high affinity and receptor selectivity of steroidal estrogens to deliver cytotoxic agents that by themselves lack selectivity. In this review, we describe the strategies and methods employed by those investigators in their efforts to develop steroid-drug conjugates with the goals of enhanced antiproliferative activity and ER-selectivity. In particular, the choices of steroid scaffolds and sites for drug conjugation have evolved as the understanding of role of ER in cell function has expanded. Present knowledge of the mechanism of action for estrogens and antiestrogens helps explain the failure of most efforts to achieve their stated objectives. The review culminates in the description of our program, which has produced the first conjugate that clearly has achieved those goals and provides an approach for developing new agents for future clinical use.

show abstract